Other Stories

Moderna's vaccine testing produces COVID-19 antibodies in all 45 participants Updated: 2020-05-19 07:09:11 KST

U.S. biotech company Moderna says there have been some promising early results from its first human tests for a potential vaccine for COVID-19.
It said the vaccine produced virus-fighting antibodies in all 45 participants that were similar or greater than those in patients who had recovered from the virus.
The vaccine also produced neutralizing antibodies in at least eight participants, which is considered important in acquiring protection.
Approved by the FDA last month, Moderna will proceed with the second phase of testing involving 600 people.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.